Frequently asked questions

No. The Court of Justice of the EU held in Kanavape (C-663/18) that CBD is not a narcotic under the 1961 Single Convention, and the INCB’s 2026 notice itself states that pure CBD is not controlled under the international drug control conventions.

That is the claim behind the current proposals — and the INCB document advancing it concedes the evidence is “limited”. The single documented criminal case used industrial hemp, not CBD. We ask that any restriction be based on a transparent assessment of evidence, not on an evidentially limited hypothesis.

On 5 June 2026 the Czech government moved a proposal to restrict CBD on “precursor” grounds into its inter-ministerial comment procedure — an administrative stage with a fixed deadline, conducted without open public debate. The coalition is asking for the evidence behind the proposal to be published and assessed transparently before any decision.

No. We call for proportionate regulation: quality standards, contaminant testing, clear labelling, and age restrictions where relevant — and for enforcement against synthetic cannabinoids sold as “collector’s items”, which are the real public-health threat.

The WHO’s expert committee found CBD generally well tolerated with a good safety profile. Purified CBD is an authorised medicine for certain seizure disorders. For other conditions, patients’ real-world experience is an essential part of the totality of evidence — valuable on safety, tolerability and quality of life — and should not be dismissed because it does not come from randomised trials.

The coalition publishes its funding and independence policy in full and is registered in the EU Transparency Register. No industry or trade-association logo appears on our materials, and no company directs the coalition’s positions. We ask governments for transparency; we hold ourselves to the same standard.

Write to coalition@cbdhumanright.org. The appeal is an open call: we confirm your organisation’s official name and representative in writing, then add you to the signatory list. Later joining is welcome — the appeal remains open.